CanadaBis Capital (CANB) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
25 Feb, 2026Executive summary
Achieved positive operating cash flow and Adjusted EBITDA for fiscal Q1 2026, despite temporary market disruptions in British Columbia due to labor issues impacting cannabis distribution.
Management credits cost and labor efficiency initiatives and a shift toward higher-margin products for improved results.
Financial highlights
Gross revenue for Q1 2026 was $5.7 million, down from $9.6 million year-over-year.
Net revenue was $3.3 million, compared to $5.1 million in the prior year.
Gross profit reached $1.5 million, with gross margin improving to 27.0% from 22.9% year-over-year.
Net loss of $128,539, compared to net income of $321,569 in Q1 2025.
Adjusted EBITDA was $197,029, down from $675,892 year-over-year.
Cash and cash equivalents stood at $938,926 at quarter-end.
Outlook and guidance
Management remains focused on strengthening liquidity, enhancing operating performance, and advancing initiatives for long-term cash generation and stability.
Forward-looking statements highlight expectations for margin sustainability, liquidity improvement, and continued demand for extract-derived and infused cannabis products.
Latest events from CanadaBis Capital
- Q3 2024 delivered robust revenue, profit, and margin gains, fueled by innovation and efficiency.CANB
Q3 2024 - FY2024 net income reached $600,285, driven by new products and operational efficiencies.CANB
Q4 2024 - Record revenue and profitability achieved, driven by innovation and international expansion.CANB
Q1 2025 - Q2 2025 gross revenue surged 29% to $9M, with adjusted EBITDA of $434K and net earnings of $96K.CANB
Q2 2025 - Achieved positive adjusted EBITDA, improved margins, and strengthened liquidity despite market headwinds.CANB
Q3 2025 - Gross profit and adjusted EBITDA fell despite stable revenue, with new strategies set for 2026 growth.CANB
Q4 2025